Diasorin S.p.A. operates as a global developer and producer of in vitro diagnostic (IVD) systems and reagent kits used in clinical laboratories, hospitals, and medical research centers. The company's business model relies on a classic razor-and-blade commercial approach: placing automated diagnostic instrumentation—either sold directly or through reagent rental agreements—to generate predictable, recurring revenues through the high-volume sale of proprietary consumable reagent test kits.
The group operates primarily across three core reporting business segments: Immunodiagnostics, Molecular Diagnostics, and Licensed Technologies / Life Science (derived largely from the Luminex acquisition). Immunodiagnostics represents the majority of revenue (approximately 65%–70% of total sales), driven by its proprietary automated chemiluminescence immunoassay (CLIA) family of analyzers, notably the LIAISON XL and LIAISON XS, paired with a portfolio of specialty assays (such as Vitamin D, latent tuberculosis, gastrointestinal infections, Lyme disease, and endocrinology markers). Molecular Diagnostics contributes around 15%–20% of revenues, delivering automated real-time PCR and multiplex syndromic testing via systems like the Simplexa and LIAISON PLEX platforms. The Licensed Technologies segment (roughly 12%–15% of revenue) commercializes multiplex bead-based testing technologies, including xMAP multiplexing solutions and related consumables sold to life science research and diagnostic partner companies.
Geographically, Diasorin possesses a broad international footprint, generating more than 50% of its revenues from North America, followed by Western Europe (with Italy representing around 15%), and the remainder distributed across Latin America, Asia-Pacific, and the Middle East. The company operates major manufacturing and research facilities across Italy, the United States, Canada, Germany, and the United Kingdom, competing globally with major diagnostic providers including Roche Diagnostics, Abbott Laboratories, bioMérieux, Siemens Healthineers, and QuidelOrtho.
